Bayer Q1 sales roseChristian Fernsby ▼ | April 25, 2019
The Bayer Group achieved a strong start to the year in its operational business.
Bayer EBITDA before special items advanced 44.6 percent to 4.188 billion euros
EBITDA before special items advanced 44.6 percent to 4.188 billion euros, despite negative currency effects diminishing earnings of the pre-acquisition Bayer businesses 110 million euros.
The principal charges concerned were a total of 492 million euros in connection with the acquisition and integration of Monsanto, and 393 million euros pertaining to the announced restructuring.
Net income declined 36.5 percent to 1.241 billion euros due to high special charges.
By contrast, core earnings per share rose 13.8 percent to 2.55 euros despite the increased number of shares.
Bayer's free cash flow almost doubled to 508 million euros.
Net financial debt as of March 31, 2019, increased to 36.740 billion euros, up 3.0 percent from December 31, 2018, due to negative currency effects and the first-time application of IFRS 16, the new leases standard. ■